Maternal malnutrition in the etiopathogenesis of psychiatric diseases: Role of polyunsaturated fatty acids

Brain Sciences

Volumn 6, Issue 3, 2016, Pages

  Morgese, Maria Grazia ^a   Trabace, Luigia ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Anxiety; Attention deficit disorder; Autism spectrum disorder; Depression; Maternal malnutrition; Polyunsaturated fatty acids; Schizophrenia spectrum disorder

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOCORTICOID RECEPTOR; NEUROTROPHIC FACTOR; POLYUNSATURATED FATTY ACID;

ALZHEIMER DISEASE; ANXIETY; ATTENTION DEFICIT DISORDER; AUTISM; BRAIN DEVELOPMENT; CONNECTOME; DEPRESSION; GLUCOSE TOLERANCE; HUMAN; INFLAMMATION; LEARNING AND MEMORY TEST; MALNUTRITION; MENTAL DISEASE; MOOD DISORDER; REVIEW;

EID: 85013955214     PISSN: None     EISSN: 20763425     Source Type: Journal    
DOI: 10.3390/brainsci6030024     Document Type: Review

References (221)

1. Lyall, K., Schmidt, R.J., Hertz-Picciotto, I. Maternal lifestyle and environmental risk factors for autism spectrum disorders. Int. J. Epidemiol. 2014, 43, 443-464. [CrossRef] [PubMed]
2. Monk, C., Georgieff, M.K., Osterholm, E.A. Research review: Maternal prenatal distress and poor nutrition—Mutually influencing risk factors affecting infant neurocognitive development. J. Child Psychol. Psychiatry Allied Discip. 2013, 54, 115-130. [CrossRef] [PubMed]
3. Bao, Y., Ibram, G., Blaner, W.S., Quesenberry, C.P., Shen, L., McKeague, I.W., Schaefer, C.A., Susser, E.S., Brown, A.S. Low maternal retinol as a risk factor for schizophrenia in adult offspring. Schizophr. Res. 2012, 137, 159-165. [CrossRef] [PubMed]
4. Roseboom, T.J., Painter, R.C., van Abeelen, A.F., Veenendaal, M.V., de Rooij, S.R. Hungry in the womb: What are the consequences? Lessons from the dutch famine. Maturitas 2011, 70, 141-145. [CrossRef] [PubMed]
5. Sullivan, E.L., Riper, K.M., Lockard, R., Valleau, J.C. Maternal high-fat diet programming of the neuroendocrine system and behavior. Horm. Behav. 2015, 76, 153-161. [CrossRef] [PubMed]
6. Wenk, M.R. The emerging field of lipidomics. Nat. Rev. Drug Discov. 2005, 4, 594-610. [CrossRef] [PubMed]
7. Luchtman, D.W., Song, C. Cognitive enhancement by omega-3 fatty acids from child-hood to old age: Findings from animal and clinical studies. Neuropharmacology 2013, 64, 550-565. [CrossRef] [PubMed]
8. Gerster, H. Can adults adequately convert α-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? Int. J. Vitam. Nutr. Res. 1998, 68, 159-173. [PubMed]
9. Lauritzen, L., Hansen, H.S., Jorgensen, M.H., Michaelsen, K.F. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog. Lipid Res. 2001, 40, 1-94. [CrossRef]
10. Singh, M. Essential fatty acids, dha and human brain. Indian J. Pediatrics 2005, 72, 239-242. [CrossRef]
11. Spector, A.A. Essentiality of fatty acids. Lipids 1999, 34, S1-S3. [CrossRef] [PubMed]
12. Fernstrom, J.D. Effects of dietary polyunsaturated fatty acids on neuronal function. Lipids 1999, 34, 161-169. [CrossRef] [PubMed]
13. McNamara, R.K., Strawn, J.R. Role of long-chain omega-3 fatty acids in psychiatric practice. PharmaNutrition 2013, 1, 41-49. [CrossRef] [PubMed]
14. Youdim, K.A., Martin, A., Joseph, J.A. Essential fatty acids and the brain: Possible health implications. Int. J. Dev. Neurosci. 2000, 18, 383-399. [CrossRef]
15. Young, G., Conquer, J. Omega-3 fatty acids and neuropsychiatric disorders. Reprod. Nutr. Dev. 2005, 45, 1-28. [CrossRef] [PubMed]
16. Chen, C.T., Liu, Z., Ouellet, M., Calon, F., Bazinet, R.P. Rapid β-oxidation of eicosapentaenoic acid in mouse brain: An in situ study. Prostaglandins Leukot. Essent. Fatty Acids 2009, 80, 157-163. [CrossRef] [PubMed]
17. Chen, C.T., Liu, Z., Bazinet, R.P. Rapid de-esterification and loss of eicosapentaenoic acid from rat brain phospholipids: An intracerebroventricular study. J. Neurochem. 2011, 116, 363-373. [CrossRef] [PubMed]
18. Chen, C.T., Bazinet, R.P. β -oxidation and rapid metabolism, but not uptake regulate brain eicosapentaenoic acid levels. Prostaglandins Leukot. Essent. Fatty Acids 2015, 92, 33-40. [CrossRef] [PubMed]
19. Kaur, G., Begg, D.P., Barr, D., Garg, M., Cameron-Smith, D., Sinclair, A.J. Short-term docosapentaenoic acid (22:5n-3) supplementation increases tissue docosapentaenoic acid, DHA and EPA concentrations in rats. Br. J. Nutr. 2010, 103, 32-37. [CrossRef] [PubMed]
20. Kaur, G., Cameron-Smith, D., Garg, M., Sinclair, A.J. Docosapentaenoic acid (22:5n-3): A review of its biological effects. Prog. Lipid Res. 2011, 50, 28-34. [CrossRef] [PubMed]
21. Lim, S.Y., Hoshiba, J., Salem, N., Jr. An extraordinary degree of structural specificity is required in neural phospholipids for optimal brain function: n-6 docosapentaenoic acid substitution for docosahexaenoic acid leads to a loss in spatial task performance. J. Neurochem. 2005, 95, 848-857. [CrossRef] [PubMed]
22. Simopoulos, A.P. Importance of the omega-6/omega-3 balance in health and disease: Evolutionary aspects of diet. World Rev. Nutr. Diet. 2011, 102, 10-21. [PubMed]
23. Simopoulos, A.P. Omega-6/omega-3 essential fatty acids: Biological effects. World Rev. Nutr. Diet. 2009, 99, 1-16. [PubMed]
24. Simopoulos, A.P. Evolutionary aspects of the dietary omega-6:Omega-3 fatty acid ratio: Medical implications. World Rev. Nutr. Diet. 2009, 100, 1-21. [PubMed]
25. Meyer, B.J., Mann, N.J., Lewis, J.L., Milligan, G.C., Sinclair, A.J., Howe, P.R. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 2003, 38, 391-398. [CrossRef] [PubMed]
26. Sinclair, A.J., Attar-Bashi, N.M., Li, D. What is the role of α-linolenic acid for mammals? Lipids 2002, 37, 1113-1123. [CrossRef] [PubMed]
27. Simopoulos, A.P. Evolutionary aspects of diet: The omega-6/omega-3 ratio and the brain. Mol. Neurobiol. 2011, 44, 203-215. [CrossRef] [PubMed]
28. Hagve, T.A., Christophersen, B.O. Effect of dietary fats on arachidonic acid and eicosapentaenoic acid biosynthesis and conversion to C 22 fatty acids in isolated rat liver cells. Biochim. Biophys. Acta 1984, 796, 205-217. [CrossRef]
29. Hagve, T.A., Christophersen, B.O. Evidence for peroxisomal retroconversion of adrenic acid (22:4(n-6)) and docosahexaenoic acids (22:6(n-3)) in isolated liver cells. Biochim. Biophys. Acta 1986, 875, 165-173. [CrossRef]
30. Smink, W., Gerrits, W.J., Gloaguen, M., Ruiter, A., van Baal, J. Linoleic and α-linolenic acid as precursor and inhibitor for the synthesis of long-chain polyunsaturated fatty acids in liver and brain of growing pigs. Animal 2012, 6, 262-270. [CrossRef] [PubMed]
31. Innis, S.M. Dietary (n-3) fatty acids and brain development. J. Nutr. 2007, 137, 855-859. [PubMed]
32. McNamara, R.K., Vannest, J.J., Valentine, C.J. Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology. World J. Psychiatry 2015, 5, 15-34. [PubMed]
33. Carver, J.D., Benford, V.J., Han, B., Cantor, A.B. The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Brain Res. Bull. 2001, 56, 79-85. [CrossRef]
34. Arterburn, L.M., Hall, E.B., Oken, H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 2006, 83, 1467-1476.
35. Barcelo-Coblijn, G., Murphy, E.J., Othman, R., Moghadasian, M.H., Kashour, T., Friel, J.K. Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: A multiple-dosing trial comparing 2 sources of n-3 fatty acid. Am. J. Clin. Nutr. 2008, 88, 801-809. [PubMed]
36. Francois, C.A., Connor, S.L., Bolewicz, L.C., Connor, W.E. Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk. Am. J. Clin. Nutr. 2003, 77, 226-233. [PubMed]
37. Valentine, C.J., Morrow, G., Pennell, M., Morrow, A.L., Hodge, A., Haban-Bartz, A., Collins, K., Rogers, L.K. Randomized controlled trial of docosahexaenoic acid supplementation in midwestern US human milk donors. Breastfeed. Med. 2013, 8, 86-91. [CrossRef] [PubMed]
38. Lin, Y.H., Shah, S., Salem, N., Jr. Altered essential fatty acid metabolism and composition in rat liver, plasma, heart and brain after microalgal DHA addition to the diet. J. Nutr. Biochem. 2011, 22, 758-765. [CrossRef] [PubMed]
39. Su, H.M., Bernardo, L., Mirmiran, M., Ma, X.H., Corso, T.N., Nathanielsz, P.W., Brenna, J.T. Bioequivalence of dietary α-linolenic and docosahexaenoic acids as sources of docosahexaenoate accretion in brain and associated organs of neonatal baboons. Pediatr. Res. 1999, 45, 87-93. [CrossRef] [PubMed]
40. Rodriguez, A., Sarda, P., Nessmann, C., Boulot, P., Leger, C.L., Descomps, B. Delta6- and delta5-desaturase activities in the human fetal liver: Kinetic aspects. J. Lipid Res. 1998, 39, 1825-1832. [PubMed]
41. Clandinin, M.T., Chappell, J.E., Leong, S., Heim, T., Swyer, P.R., Chance, G.W. Intrauterine fatty acid accretion rates in human brain: Implications for fatty acid requirements. Early Hum. Dev. 1980, 4, 121-129. [CrossRef]
42. Martinez, M. Tissue levels of polyunsaturated fatty acids during early human development. J. Pediatr. 1992, 120, 129-138. [CrossRef]
43. Guesnet, P., Alessandri, J.M. Docosahexaenoic acid (DHA) and the developing central nervous system (CNS)—Implications for dietary recommendations. Biochimie 2011, 93, 7-12. [CrossRef] [PubMed]
44. Schiefermeier, M., Yavin, E. n-3 deficient and docosahexaenoic acid-enriched diets during critical periods of the developing prenatal rat brain. J. Lipid Res. 2002, 43, 124-131. [PubMed]
45. Giedd, J.N., Lalonde, F.M., Celano, M.J., White, S.L., Wallace, G.L., Lee, N.R., Lenroot, R.K. Anatomical brain magnetic resonance imaging of typically developing children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry 2009, 48, 465-470. [PubMed]
46. Paus, T., Zijdenbos, A., Worsley, K., Collins, D.L., Blumenthal, J., Giedd, J.N., Rapoport, J.L., Evans, A.C. Structural maturation of neural pathways in children and adolescents: In vivo study. Science 1999, 283, 1908-1911. [CrossRef] [PubMed]
47. Sowell, E.R., Thompson, P.M., Holmes, C.J., Batth, R., Jernigan, T.L., Toga, A.W. Localizing age-related changes in brain structure between childhood and adolescence using statistical parametric mapping. NeuroImage 1999, 9, 587-597. [CrossRef] [PubMed]
48. Green, P., Yavin, E. Fatty acid composition of late embryonic and early postnatal rat brain. Lipids 1996, 31, 859-865. [CrossRef] [PubMed]
49. Heinrichs, S.C. Dietary omega-3 fatty acid supplementation for optimizing neuronal structure and function. Mol. Nutr. Food Res. 2010, 54, 447-456. [CrossRef] [PubMed]
50. Alessandri, J.M., Guesnet, P., Vancassel, S., Astorg, P., Denis, I., Langelier, B., Aid, S., Poumes-Ballihaut, C., Champeil-Potokar, G., Lavialle, M. Polyunsaturated fatty acids in the central nervous system: Evolution of concepts and nutritional implications throughout life. Reprod. Nutr. Dev. 2004, 44, 509-538. [CrossRef] [PubMed]
51. Hamilton, L., Greiner, R., Salem, N., Jr., Kim, H.Y. n-3 fatty acid deficiency decreases phosphatidylserine accumulation selectively in neuronal tissues. Lipids 2000, 35, 863-869. [CrossRef] [PubMed]
52. Madore, C., Nadjar, A., Delpech, J.C., Sere, A., Aubert, A., Portal, C., Joffre, C., Laye, S. Nutritional n-3 PUFAs deficiency during perinatal periods alters brain innate immune system and neuronal plasticity-associated genes. Brain Behav. Immun. 2014, 41, 22-31. [CrossRef] [PubMed]
53. 2 elevation in the prefrontal cortex of an animal model of psychosis. Mol. Neurobiol. 2016. [CrossRef] [PubMed]
54. Wilhelm, J., Ivica, J., Kagan, D., Svoboda, P. Early postnatal development of rat brain is accompanied by generation of lipofuscin-like pigments. Mol. Cell. Biochem. 2011, 347, 157-162. [CrossRef] [PubMed]
55. Fernandez, A.P., Alonso, D., Lisazoain, I., Serrano, J., Leza, J.C., Bentura, M.L., Lopez, J.C., Manuel Encinas, J., Fernandez-Vizarra, P., Castro-Blanco, S., et al. Postnatal changes in the nitric oxide system of the rat cerebral cortex after hypoxia during delivery. Brain Res. Dev. Brain Res. 2003, 142, 177-192. [CrossRef]
56. Wilhelm, J., Vytasek, R., Uhlik, J., Vajner, L. Oxidative stress in the developing rat brain due to production of reactive oxygen and nitrogen species. Oxid. Med. Cell. Longev. 2016, 2016, 5057610. [CrossRef] [PubMed]
57. Kuan, C.Y., Roth, K.A., Flavell, R.A., Rakic, P. Mechanisms of programmed cell death in the developing brain. Trends Neurosci. 2000, 23, 291-297. [CrossRef]
58. Marin-Teva, J.L., Dusart, I., Colin, C., Gervais, A., van Rooijen, N., Mallat, M. Microglia promote the death of developing purkinje cells. Neuron 2004, 41, 535-547. [CrossRef]
59. Haynes, R.L., Folkerth, R.D., Szweda, L.I., Volpe, J.J., Kinney, H.C. Lipid peroxidation during human cerebral myelination. J. Neuropathol. Exp. Neurol. 2006, 65, 894-904. [CrossRef] [PubMed]
60. Pase, C.S., Roversi, K., Trevizol, F., Roversi, K., Kuhn, F.T., Schuster, A.J., Vey, L.T., Dias, V.T., Barcelos, R.C., Piccolo, J., et al. Influence of perinatal trans fat on behavioral responses and brain oxidative status of adolescent rats acutely exposed to stress. Neuroscience 2013, 247, 242-252. [CrossRef] [PubMed]
61. Niemoller, T.D., Bazan, N.G. Docosahexaenoic acid neurolipidomics. Prostaglandins Other Lipid Med. 2010, 91, 85-89. [CrossRef] [PubMed]
62. Jones, M.L., Mark, P.J., Waddell, B.J. Maternal dietary omega-3 fatty acids and placental function. Reproduction 2014, 147, 143-152. [CrossRef] [PubMed]
63. Jones, M.L., Mark, P.J., Mori, T.A., Keelan, J.A., Waddell, B.J. Maternal dietary omega-3 fatty acid supplementation reduces placental oxidative stress and increases fetal and placental growth in the rat. Biol. Reprod. 2013, 88, 37. [CrossRef] [PubMed]
64. Fernandez-Ruiz, J.J., Berrendero, F., Hernandez, M.L., Romero, J., Ramos, J.A. Role of endocannabinoids in brain development. Life Sci. 1999, 65, 725-736. [CrossRef]
65. Aguado, T., Palazuelos, J., Monory, K., Stella, N., Cravatt, B., Lutz, B., Marsicano, G., Kokaia, Z., Guzman, M., Galve-Roperh, I. The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J. Neurosci. 2006, 26, 1551-1561. [CrossRef] [PubMed]
66. Guzman, M., Sanchez, C., Galve-Roperh, I. Cannabinoids and cell fate. Pharmacol. Ther. 2002, 95, 175-184. [CrossRef]
67. Berghuis, P., Rajnicek, A.M., Morozov, Y.M., Ross, R.A., Mulder, J., Urban, G.M., Monory, K., Marsicano, G., Matteoli, M., Canty, A., et al. Hardwiring the brain: Endocannabinoids shape neuronal connectivity. Science 2007, 316, 1212-1216. [CrossRef] [PubMed]
68. Mulder, J., Aguado, T., Keimpema, E., Barabas, K., Ballester Rosado, C.J., Nguyen, L., Monory, K., Marsicano, G., Di Marzo, V., Hurd, Y.L., et al. Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc. Natl. Acad. Sci. USA 2008, 105, 8760-8765. [CrossRef] [PubMed]
69. Innis, S.M. Metabolic programming of long-term outcomes due to fatty acid nutrition in early life. Matern. Child Nutr. 2011, 7, 112-123. [CrossRef] [PubMed]
70. Calder, P.C., Kremmyda, L.S., Vlachava, M., Noakes, P.S., Miles, E.A. Is there a role for fatty acids in early life programming of the immune system? Proc. Nutr. Soc. 2010, 69, 373-380. [CrossRef] [PubMed]
71. Barker, D.J. The wellcome foundation lecture, 1994. The fetal origins of adult disease. Proc. Biol. Sci. R. Soc. 1995, 262, 37-43. [CrossRef] [PubMed]
72. Tarry-Adkins, J.L., Ozanne, S.E. Mechanisms of early life programming: Current knowledge and future directions. Am. J. Clin. Nutr. 2011, 94, 1765-1771. [CrossRef] [PubMed]
73. Snoeck, A., Remacle, C., Reusens, B., Hoet, J.J. Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas. Biol. Neonate 1990, 57, 107-118. [CrossRef] [PubMed]
74. Petry, C.J., Ozanne, S.E., Wang, C.L., Hales, C.N. Effects of early protein restriction and adult obesity on rat pancreatic hormone content and glucose tolerance. Horm. Metab. Res. 2000, 32, 233-239. [CrossRef] [PubMed]
75. Langley-Evans, S.C., Welham, S.J., Sherman, R.C., Jackson, A.A. Weanling rats exposed to maternal low-protein diets during discrete periods of gestation exhibit differing severity of hypertension. Clin. Sci. 1996, 91, 607-615. [CrossRef] [PubMed]
76. Woods, L.L., Ingelfinger, J.R., Nyengaard, J.R., Rasch, R. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr. Res. 2001, 49, 460-467. [CrossRef] [PubMed]
77. Lewis, R.M., Forhead, A.J., Petry, C.J., Ozanne, S.E., Hales, C.N. Long-term programming of blood pressure by maternal dietary iron restriction in the rat. Br. J. Nutr. 2002, 88, 283-290. [CrossRef] [PubMed]
78. Langley-Evans, S.C., Gardner, D.S., Jackson, A.A. Maternal protein restriction influences the programming of the rat hypothalamic-pituitary-adrenal axis. J. Nutr. 1996, 126, 1578-1585. [PubMed]
79. Gambling, L., Charania, Z., Hannah, L., Antipatis, C., Lea, R.G., McArdle, H.J. Effect of iron deficiency on placental cytokine expression and fetal growth in the pregnant rat. Biol. Reprod. 2002, 66, 516-523. [CrossRef] [PubMed]
80. Lisle, S.J., Lewis, R.M., Petry, C.J., Ozanne, S.E., Hales, C.N., Forhead, A.J. Effect of maternal iron restriction during pregnancy on renal morphology in the adult rat offspring. Br. J. Nutr. 2003, 90, 33-39. [CrossRef] [PubMed]
81. Aravidou, E., Eleftheriades, M., Malamitsi-Puchner, A., Anagnostopoulos, A.K., Aravantinos, L., Dontas, I., Aravidis, C., Creatsas, G., Tsangaris, G., Chrousos, G.P. Protein expression in the brain of rat offspring in relation to prenatal caloric restriction. J. Matern. Fetal Neonatal Med. 2016, 29, 2707-2714. [CrossRef] [PubMed]
82. Garofano, A., Czernichow, P., Breant, B. Effect of ageing on β -cell mass and function in rats malnourished during the perinatal period. Diabetologia 1999, 42, 711-718. [CrossRef] [PubMed]
83. Armitage, J.A., Khan, I.Y., Taylor, P.D., Nathanielsz, P.W., Poston, L. Developmental programming of the metabolic syndrome by maternal nutritional imbalance: How strong is the evidence from experimental models in mammals? J. Physiol. 2004, 561, 355-377. [CrossRef] [PubMed]
84. Palinski, W., D’Armiento, F.P., Witztum, J.L., de Nigris, F., Casanada, F., Condorelli, M., Silvestre, M., Napoli, C. Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits. Circ. Res. 2001, 89, 991-996. [CrossRef] [PubMed]
85. Taylor, P.D., McConnell, J., Khan, I.Y., Holemans, K., Lawrence, K.M., Asare-Anane, H., Persaud, S.J., Jones, P.M., Petrie, L., Hanson, M.A., et al. Impaired glucose homeostasis and mitochondrial abnormalities in offspring of rats fed a fat-rich diet in pregnancy. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288, 134-139. [CrossRef] [PubMed]
86. Sullivan, E.L., Grayson, B., Takahashi, D., Robertson, N., Maier, A., Bethea, C.L., Smith, M.S., Coleman, K., Grove, K.L. Chronic consumption of a high-fat diet during pregnancy causes perturbations in the serotonergic system and increased anxiety-like behavior in nonhuman primate offspring. J. Neurosci. 2010, 30, 3826-3830. [CrossRef] [PubMed]
87. Page, K.C., Jones, E.K., Anday, E.K. Maternal and postweaning high-fat diets disturb hippocampal gene expression, learning, and memory function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2014, 306, 527-537. [CrossRef] [PubMed]
88. Silberman, D.M., Acosta, G.B., Zorrilla Zubilete, M.A. Long-term effects of early life stress exposure: Role of epigenetic mechanisms. Pharmacol. Res. 2016, 109, 64-73. [CrossRef] [PubMed]
89. Mhillaj, E., Morgese, M.G., Trabace, L. Early life and oxidative stress in psychiatric disorders: What can we learn from animal models? Curr. Pharm. Des. 2015, 21, 1396-1403. [CrossRef] [PubMed]
90. Weinstock, M. Alterations induced by gestational stress in brain morphology and behaviour of the offspring. Prog. Neurobiol. 2001, 65, 427-451. [CrossRef]
91. Levitt, N.S., Lindsay, R.S., Holmes, M.C., Seckl, J.R. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 1996, 64, 412-418. [CrossRef] [PubMed]
92. Welberg, L.A., Seckl, J.R., Holmes, M.C. Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: Possible implications for behaviour. Neuroscience 2001, 104, 71-79. [CrossRef]
93. Edwards, C.R., Benediktsson, R., Lindsay, R.S., Seckl, J.R. 11β-hydroxysteroid dehydrogenases: Key enzymes in determining tissue-specific glucocorticoid effects. Steroids 1996, 61, 263-269. [CrossRef]
94. Jensen Pena, C., Monk, C., Champagne, F.A. Epigenetic effects of prenatal stress on 11 β -hydroxysteroid dehydrogenase-2 in the placenta and fetal brain. PLoS ONE 2012, 7, e39791. [CrossRef] [PubMed]
95. Mairesse, J., Lesage, J., Breton, C., Breant, B., Hahn, T., Darnaudery, M., Dickson, S.L., Seckl, J., Blondeau, B., Vieau, D., et al. Maternal stress alters endocrine function of the feto-placental unit in rats. Am. J. Physiol. Endocrinol. Metab. 2007, 292, 1526-1533. [CrossRef] [PubMed]
96. O’Donnell, K.J., Bugge Jensen, A., Freeman, L., Khalife, N., O’Connor, T.G., Glover, V. Maternal prenatal anxiety and downregulation of placental 11β-HSD2. Psychoneuroendocrinology 2012, 37, 818-826. [CrossRef] [PubMed]
97. Mueller, B.R., Bale, T.L. Sex-specific programming of offspring emotionality after stress early in pregnancy. J. Neurosci. 2008, 28, 9055-9065. [CrossRef] [PubMed]
98. Larrieu, T., Hilal, M.L., Fourrier, C., De Smedt-Peyrusse, V., Sans, N., Capuron, L., Laye, S. Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion. Transl. Psychiatry 2014, 4, e437. [CrossRef] [PubMed]
99. Morgese, M.G., Tucci, P., Mhillaj, E., Bove, M., Schiavone, S., Trabace, L., Cuomo, V. Lifelong nutritional omega-3 deficiency evokes depressive-like state through soluble β amyloid. Mol. Neurobiol. 2016. [CrossRef] [PubMed]
100. Stetler, C., Miller, G.E. Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. Psychosom. Med. 2011, 73, 114-126. [CrossRef] [PubMed]
101. Colaianna, M., Schiavone, S., Zotti, M., Tucci, P., Morgese, M.G., Backdahl, L., Holmdahl, R., Krause, K.H., Cuomo, V., Trabace, L. Neuroendocrine profile in a rat model of psychosocial stress: Relation to oxidative stress. Antioxid. Redox Signal. 2013, 18, 1385-1399. [CrossRef] [PubMed]
102. Slavich, G.M., Irwin, M.R. From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Psychol. Bull. 2014, 140, 774-815. [CrossRef] [PubMed]
103. Colangelo, L.A., He, K., Whooley, M.A., Daviglus, M.L., Liu, K. Higher dietary intake of long-chain omega-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition 2009, 25, 1011-1019. [CrossRef] [PubMed]
104. Panagiotakos, D.B., Mamplekou, E., Pitsavos, C., Kalogeropoulos, N., Kastorini, C.M., Papageorgiou, C., Papadimitriou, G.N., Stefanadis, C. Fatty acids intake and depressive symptomatology in a greek sample: An epidemiological analysis. J. Am. College Nutr. 2010, 29, 586-594. [CrossRef]
105. Murakami, K., Miyake, Y., Sasaki, S., Tanaka, K., Arakawa, M. Fish and n-3 polyunsaturated fatty acid intake and depressive symptoms: Ryukyus child health study. Pediatrics 2010, 126, 623-630. [CrossRef] [PubMed]
106. Beydoun, M.A., Fanelli Kuczmarski, M.T., Beydoun, H.A., Rostant, O.S., Evans, M.K., Zonderman, A.B. Associations of the ratios of n-3 to n-6 dietary fatty acids with longitudinal changes in depressive symptoms among us women. Am. J. Epidemiol. 2015, 181, 691-705. [CrossRef] [PubMed]
107. Levant, B. n-3 (omega-3) polyunsaturated fatty acids in the pathophysiology and treatment of depression: Pre-clinical evidence. CNS Neurol. Disord. Drug Targets 2013, 12, 450-459. [CrossRef] [PubMed]
108. Park, Y., Moon, H.J., Kim, S.H. n-3 polyunsaturated fatty acid consumption produces neurobiological effects associated with prevention of depression in rats after the forced swimming test. J. Nutr. Biochem. 2012, 23, 924-928. [CrossRef] [PubMed]
109. Lin, P.Y., Su, K.P. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J. Clin. Psychiatry 2007, 68, 1056-1061. [CrossRef] [PubMed]
110. Grosso, G., Pajak, A., Marventano, S., Castellano, S., Galvano, F., Bucolo, C., Drago, F., Caraci, F. Role of omega-3 fatty acids in the treatment of depressive disorders: A comprehensive meta-analysis of randomized clinical trials. PLoS ONE 2014, 9, e96905. [CrossRef] [PubMed]
111. Cleare, A., Pariante, C.M., Young, A.H., Anderson, I.M., Christmas, D., Cowen, P.J., Dickens, C., Ferrier, I.N., Geddes, J., Gilbody, S., et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British association for psychopharmacology guidelines. J. Psychopharmacol. 2015, 29, 459-525. [CrossRef] [PubMed]
112. Appleton, K.M., Peters, T.J., Hayward, R.C., Heatherley, S.V., McNaughton, S.A., Rogers, P.J., Gunnell, D., Ness, A.R., Kessler, D. Depressed mood and n-3 polyunsaturated fatty acid intake from fish: Non-linear or confounded association? Soc. Psychiatry Psychiatr. Epidemiol. 2007, 42, 100-104. [CrossRef] [PubMed]
113. Larrieu, T., Madore, C., Joffre, C., Laye, S. Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice. J. Physiol. Biochem. 2012, 68, 671-681. [CrossRef] [PubMed]
114. Lafourcade, M., Larrieu, T., Mato, S., Duffaud, A., Sepers, M., Matias, I., De Smedt-Peyrusse, V., Labrousse, V.F., Bretillon, L., Matute, C., et al. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat. Neurosci. 2011, 14, 345-350. [CrossRef] [PubMed]
115. Tchantchou, F., Tucker, L.B., Fu, A.H., Bluett, R.J., McCabe, J.T., Patel, S., Zhang, Y. The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury. Neuropharmacology 2014, 85, 427-439. [CrossRef] [PubMed]
116. Boersma, G.J., Lee, R.S., Cordner, Z.A., Ewald, E.R., Purcell, R.H., Moghadam, A.A., Tamashiro, K.L. Prenatal stress decreases Bdnf expression and increases methylation of Bdnf exon IV in rats. Epigenetics 2014, 9, 437-447. [CrossRef] [PubMed]
117. Schaaf, M.J., de Jong, J., de Kloet, E.R., Vreugdenhil, E. Downregulation of Bdnf mRNA and protein in the rat hippocampus by corticosterone. Brain Res. 1998, 813, 112-120. [CrossRef]
118. Schaaf, M.J., De Kloet, E.R., Vreugdenhil, E. Corticosterone effects on Bdnf expression in the hippocampus. Implications for memory formation. Stress 2000, 3, 201-208. [CrossRef] [PubMed]
119. Sarrazin, N., Di Blasi, F., Roullot-Lacarriere, V., Rouge-Pont, F., Le Roux, A., Costet, P., Revest, J.M., Piazza, P.V. Transcriptional effects of glucocorticoid receptors in the dentate gyrus increase anxiety-related behaviors. PLoS ONE 2009, 4, e7704. [CrossRef] [PubMed]
120. Larrieu, T., Hilal, M.L., De Smedt-Peyrusse, V., Sans, N., Laye, S. Nutritional omega-3 deficiency alters glucocorticoid receptor-signaling pathway and neuronal morphology in regionally distinct brain structures associated with emotional deficits. Neural Plasticity 2016, 2016, 8574830. [CrossRef] [PubMed]
121. Sun, X., Steffens, D.C., Au, R., Folstein, M., Summergrad, P., Yee, J., Rosenberg, I., Mwamburi, D.M., Qiu, W.Q. Amyloid-associated depression: A prodromal depression of alzheimer disease? Arch. Gen. Psychiatry 2008, 65, 542-550. [CrossRef] [PubMed]
122. Pomara, N., Sidtis, J. Possible therapeutic implication of A β disturbances in depression. Int. J. Geriatr. Psychiatry 2007, 22, 931-932. [CrossRef] [PubMed]
123. Pomara, N., Sidtis, J.J. Brain neurotoxic amyloid-β peptides: Their potential role in the pathophysiology of depression and as molecular therapeutic targets. Br. J. Pharmacol. 2010, 161, 768-770. [CrossRef] [PubMed]
124. Pomara, N., Willoughby, L.M., Sidtis, J.J., Mehta, P.D. Selective reductions in plasma Aβ 1-42 in healthy elderly subjects during longitudinal follow-up: A preliminary report. Am. J. Geriatr. Psychiatry 2005, 13, 914-917. [CrossRef] [PubMed]
125. Colaianna, M., Tucci, P., Zotti, M., Morgese, M.G., Schiavone, S., Govoni, S., Cuomo, V., Trabace, L. Soluble β amyloid(1-42): A critical player in producing behavioural and biochemical changes evoking depressive-related state? Br. J. Pharmacol. 2010, 159, 1704-1715. [CrossRef] [PubMed]
126. Morgese, M.G., Colaianna, M., Mhillaj, E., Zotti, M., Schiavone, S., D’Antonio, P., Harkin, A., Gigliucci, V., Campolongo, P., Trezza, V., et al. Soluble β amyloid evokes alteration in brain norepinephrine levels: Role of nitric oxide and interleukin-1. Front. Neurosci. 2015, 9, 428. [CrossRef] [PubMed]
127. Morgese, M.G., Tucci, P., Colaianna, M., Zotti, M., Cuomo, V., Schiavone, S., Trabace, L. Modulatory activity of soluble β amyloid on HPA axis function in rats. Curr. Pharm. Des. 2014, 20, 2539-2546. [CrossRef] [PubMed]
128. Tucci, P., Mhillaj, E., Morgese, M.G., Colaianna, M., Zotti, M., Schiavone, S., Cicerale, M., Trezza, V., Campolongo, P., Cuomo, V., et al. Memantine prevents memory consolidation failure induced by soluble β amyloid in rats. Front. Behav. Neurosci. 2014, 8, 332. [CrossRef] [PubMed]
129. Grant, W.B. Trends in diet and Alzheimer’s disease during the nutrition transition in Japan and developing countries. J. Alzheimers Dis. 2014, 38, 611-620. [PubMed]
130. Calder, P.C. n-3 fatty acids, inflammation and immunity: New mechanisms to explain old actions. Proc. Nutr. Soc. 2013, 72, 326-336. [CrossRef] [PubMed]
131. James, M.J., Gibson, R.A., Cleland, L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr. 2000, 71, 343-348.
132. Graeber, M.B., Li, W., Rodriguez, M.L. Role of microglia in cns inflammation. FEBS Lett. 2011, 585, 3798-3805. [CrossRef] [PubMed]
133. Minogue, A.M., Lynch, A.M., Loane, D.J., Herron, C.E., Lynch, M.A. Modulation of amyloid-β-induced and age-associated changes in rat hippocampus by eicosapentaenoic acid. J. Neurochem. 2007, 103, 914-926. [CrossRef] [PubMed]
134. Goshen, I., Yirmiya, R. Interleukin-1 (il-1): A central regulator of stress responses. Front. Neuroendocrinol. 2009, 30, 30-45. [CrossRef] [PubMed]
135. Thomas, A.J., Davis, S., Morris, C., Jackson, E., Harrison, R., O’Brien, J.T. Increase in interleukin-1β in late-life depression. Am. J. Psychiatry 2005, 162, 175-177. [CrossRef] [PubMed]
136. Pokryszko-Dragan, A., Frydecka, I., Kosmaczewska, A., Ciszak, L., Bilinska, M., Gruszka, E., Podemski, R., Frydecka, D. Stimulated peripheral production of interferon-gamma is related to fatigue and depression in multiple sclerosis. Clin. Neurol. Neurosurg. 2012, 114, 1153-1158. [CrossRef] [PubMed]
137. Lorente-Cebrian, S., Costa, A.G., Navas-Carretero, S., Zabala, M., Laiglesia, L.M., Martinez, J.A., Moreno-Aliaga, M.J. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases. J. Physiol. Biochem. 2015, 71, 341-349. [CrossRef] [PubMed]
138. Apetz, N., Munch, G., Govindaraghavan, S., Gyengesi, E. Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer’s disease—A translational perspective. CNS Neurol. Disord. Drug Targets 2014, 13, 1175-1191. [CrossRef] [PubMed]
139. Freund-Levi, Y., Basun, H., Cederholm, T., Faxen-Irving, G., Garlind, A., Grut, M., Vedin, I., Palmblad, J., Wahlund, L.O., Eriksdotter-Jonhagen, M. Omega-3 supplementation in mild to moderate Alzheimer’s disease: Effects on neuropsychiatric symptoms. Int. J. Geriatr. Psychiatry 2008, 23, 161-169. [CrossRef] [PubMed]
140. Knochel, C., Voss, M., Gruter, F., Alves, G.S., Matura, S., Sepanski, B., Stablein, M., Kraft, D., Prvulovic, D., Carvalho, A.F., et al. Omega-3 Fatty Acids: Repurposing Opportunities for Cognition and Biobehavioral Disturbances in MCI and Dementia. Available online: http://www.ncbi.nlm.nih.gov/pubmed/27335040 (accessed on 26 July 2016).
141. Brown, A.S., Susser, E.S. Prenatal nutritional deficiency and risk of adult schizophrenia. Schizophr. Bull. 2008, 34, 1054-1063. [CrossRef] [PubMed]
142. Schiavone, S., Colaianna, M., Curtis, L. Impact of early life stress on the pathogenesis of mental disorders: Relation to brain oxidative stress. Curr. Pharm. Des. 2015, 21, 1404-1412. [CrossRef] [PubMed]
143. Greiner, R.S., Moriguchi, T., Slotnick, B.M., Hutton, A., Salem, N. Olfactory discrimination deficits in n-3 fatty acid-deficient rats. Physiol. Behav. 2001, 72, 379-385. [CrossRef]
144. Moriguchi, T., Greiner, R.S., Salem, N., Jr. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J. Neurochem. 2000, 75, 2563-2573. [CrossRef] [PubMed]
145. Wainwright, P.E., Huang, Y.S., Coscina, D.V., Levesque, S., McCutcheon, D. Brain and behavioral effects of dietary n-3 deficiency in mice: A three generational study. Dev. Psychobiol. 1994, 27, 467-487. [CrossRef] [PubMed]
146. Kodas, E., Vancassel, S., Lejeune, B., Guilloteau, D., Chalon, S. Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: Critical role of developmental stage. J. Lipid Res. 2002, 43, 1209-1219. [PubMed]
147. Colombo, J., Kannass, K.N., Shaddy, D.J., Kundurthi, S., Maikranz, J.M., Anderson, C.J., Blaga, O.M., Carlson, S.E. Maternal DHA and the development of attention in infancy and toddlerhood. Child Dev. 2004, 75, 1254-1267. [CrossRef] [PubMed]
148. Helland, I.B., Smith, L., Saarem, K., Saugstad, O.D., Drevon, C.A. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics 2003, 111, 39-44. [CrossRef]
149. Judge, M.P., Harel, O., Lammi-Keefe, C.J. Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: Benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo. Am. J. Clin. Nutr. 2007, 85, 1572-1577. [PubMed]
150. Levant, B., Radel, J.D., Carlson, S.E. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav. Brain Res. 2004, 152, 49-57. [CrossRef] [PubMed]
151. McNamara, R.K., Carlson, S.E. Role of omega-3 fatty acids in brain development and function: Potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75, 329-349. [CrossRef] [PubMed]
152. Zimmer, L., Delpal, S., Guilloteau, D., Aioun, J., Durand, G., Chalon, S. Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex. Neurosci. Lett. 2000, 284, 25-28. [CrossRef]
153. Brown, A.S., Susser, E.S., Butler, P.D., Richardson Andrews, R., Kaufmann, C.A., Gorman, J.M. Neurobiological plausibility of prenatal nutritional deprivation as a risk factor for schizophrenia. J. Nerv. Mental Dis. 1996, 184, 71-85. [CrossRef]
154. Liu, Y., Jandacek, R., Rider, T., Tso, P., McNamara, R.K. Elevated delta-6 desaturase (FADS2) expression in the postmortem prefrontal cortex of schizophrenic patients: Relationship with fatty acid composition. Schizophr. Res. 2009, 109, 113-120. [CrossRef] [PubMed]
155. Evans, D.R., Parikh, V.V., Khan, M.M., Coussons, C., Buckley, P.F., Mahadik, S.P. Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins Leukot. Essent. Fatty Acids 2003, 69, 393-399. [CrossRef] [PubMed]
156. Kaddurah-Daouk, R., McEvoy, J., Baillie, R.A., Lee, D., Yao, J.K., Doraiswamy, P.M., Krishnan, K.R. Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol. Psychiatry 2007, 12, 934-945. [CrossRef] [PubMed]
157. Mahadik, S.P., Shendarkar, N.S., Scheffer, R.E., Mukherjee, S., Correnti, E.E. Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls. Prostaglandins Leukot. Essent. Fatty Acids 1996, 55, 65-70. [CrossRef]
158. Horrobin, D.F., Glen, A.I., Vaddadi, K. The membrane hypothesis of schizophrenia. Schizophr. Res. 1994, 13, 195-207. [CrossRef]
159. Peet, M., Laugharne, J., Rangarajan, N., Horrobin, D., Reynolds, G. Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients. J. Psychiatr. Res. 1995, 29, 227-232. [CrossRef]
160. Reddy, R.D., Keshavan, M.S., Yao, J.K. Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophr. Bull. 2004, 30, 901-911. [CrossRef] [PubMed]
161. Hoen, W.P., Lijmer, J.G., Duran, M., Wanders, R.J., van Beveren, N.J., de Haan L. Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: A meta-analysis. Psychiatry Res. 2013, 207, 1-12. [CrossRef] [PubMed]
162. Dunstan, J.A., Simmer, K., Dixon, G., Prescott, S.L. Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: A randomised controlled trial. Arch. Dis. Child. Fetal Neonatal Ed. 2008, 93, 45-50. [CrossRef] [PubMed]
163. Hibbeln, J.R., Davis, J.M., Steer, C., Emmett, P., Rogers, I., Williams, C., Golding, J. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): An observational cohort study. Lancet 2007, 369, 578-585. [CrossRef]
164. Knable, M.B., Weinberger, D.R. Dopamine, the prefrontal cortex and schizophrenia. J. Psychopharmacol. 1997, 11, 123-131. [CrossRef] [PubMed]
165. Deutch, A.Y. The regulation of subcortical dopamine systems by the prefrontal cortex: Interactions of central dopamine systems and the pathogenesis of schizophrenia. J. Neural Transm. 1992, 36, 61-89.
166. Anderson, G.J., Neuringer, M., Lin, D.S., Connor, W.E. Can prenatal n-3 fatty acid deficiency be completely reversed after birth? Effects on retinal and brain biochemistry and visual function in rhesus monkeys. Pediatr. Res. 2005, 58, 865-872. [CrossRef] [PubMed]
167. Chung, W.L., Chen, J.J., Su, H.M. Fish oil supplementation of control and (n-3) fatty acid-deficient male rats enhances reference and working memory performance and increases brain regional docosahexaenoic acid levels. J. Nutr. 2008, 138, 1165-1171. [PubMed]
168. Moriguchi, T., Loewke, J., Garrison, M., Catalan, J.N., Salem, N. Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum. J. Lipid Res. 2001, 42, 419-427. [PubMed]
169. Wainwright, P.E. Dietary essential fatty acids and brain function: A developmental perspective on mechanisms. Proc. Nutr. Soc. 2002, 61, 61-69. [CrossRef] [PubMed]
170. Delion, S., Chalon, S., Guilloteau, D., Besnard, J.C., Durand, G. α-linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J. Neurochem. 1996, 66, 1582-1591. [CrossRef] [PubMed]
171. Delion, S., Chalon, S., Herault, J., Guilloteau, D., Besnard, J.C., Durand, G. Chronic dietary α-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J. Nutr. 1994, 124, 2466-2476. [PubMed]
172. Lyall, K., Constantino, J.N., Weisskopf, M.G., Roberts, A.L., Ascherio, A., Santangelo, S.L. Parental social responsiveness and risk of autism spectrum disorder in offspring. JAMA Psychiatry 2014, 71, 936-942. [CrossRef] [PubMed]
173. Acosta, M.T., Pearl, P.L. Imaging data in autism: From structure to malfunction. Semin. Pediatr. Neurol. 2004, 11, 205-213. [CrossRef] [PubMed]
174. Amaral, D.G., Schumann, C.M., Nordahl, C.W. Neuroanatomy of autism. Trends Neurosci. 2008, 31, 137-145. [CrossRef] [PubMed]
175. Miles, J.H. Autism spectrum disorders—A genetics review. Genet. Med. 2011, 13, 278-294. [CrossRef] [PubMed]
176. Newschaffer, C.J., Croen, L.A., Daniels, J., Giarelli, E., Grether, J.K., Levy, S.E., Mandell, D.S., Miller, L.A., Pinto-Martin, J., Reaven, J., et al. The epidemiology of autism spectrum disorders. Ann. Rev. Public Health 2007, 28, 235-258. [CrossRef] [PubMed]
177. Hecht, P.M., Hudson, M., Connors, S.L., Tilley, M.R., Liu, X., Beversdorf, D.Q. Maternal serotonin transporter genotype affects risk for asd with exposure to prenatal stress. Autism Res. 2016. [CrossRef] [PubMed]
178. Roberts, A.L., Lyall, K., Rich-Edwards, J.W., Ascherio, A., Weisskopf, M.G. Maternal exposure to intimate partner abuse before birth is associated with autism spectrum disorder in offspring. Autism 2016, 20, 26-36. [CrossRef] [PubMed]
179. Kinney, D.K., Miller, A.M., Crowley, D.J., Huang, E., Gerber, E. Autism prevalence following prenatal exposure to hurricanes and tropical storms in Louisiana. J. Autism Dev. Disord. 2008, 38, 481-488. [CrossRef] [PubMed]
180. Larsson, H.J., Eaton, W.W., Madsen, K.M., Vestergaard, M., Olesen, A.V., Agerbo, E., Schendel, D., Thorsen, P., Mortensen, P.B. Risk factors for autism: Perinatal factors, parental psychiatric history, and socioeconomic status. Am. J. Epidemiol. 2005, 161, 916-925. [CrossRef] [PubMed]
181. Beversdorf, D.Q., Manning, S.E., Hillier, A., Anderson, S.L., Nordgren, R.E., Walters, S.E., Nagaraja, H.N., Cooley, W.C., Gaelic, S.E., Bauman, M.L. Timing of prenatal stressors and autism. J. Autism Dev. Disord. 2005, 35, 471-478. [CrossRef] [PubMed]
182. Gardener, H., Spiegelman, D., Buka, S.L. Prenatal risk factors for autism: Comprehensive meta-analysis. Br. J. Psychiatry 2009, 195, 7-14. [CrossRef] [PubMed]
183. Jones, K.L., Will, M.J., Hecht, P.M., Parker, C.L., Beversdorf, D.Q. Maternal diet rich in omega-6 polyunsaturated fatty acids during gestation and lactation produces autistic-like sociability deficits in adult offspring. Behav. Brain Res. 2013, 238, 193-199. [CrossRef] [PubMed]
184. Delorme, R., Ey, E., Toro, R., Leboyer, M., Gillberg, C., Bourgeron, T. Progress toward treatments for synaptic defects in autism. Nat. Med. 2013, 19, 685-694. [CrossRef] [PubMed]
185. Courchesne, E. Abnormal early brain development in autism. Mol. Psychiatry 2002, 7, 21-23. [CrossRef] [PubMed]
186. Courchesne, E., Pierce, K. Brain overgrowth in autism during a critical time in development: Implications for frontal pyramidal neuron and interneuron development and connectivity. Int. J. Dev. Neurosci. 2005, 23, 153-170. [CrossRef] [PubMed]
187. Herbert, M.R., Ziegler, D.A., Deutsch, C.K., O’Brien, L.M., Kennedy, D.N., Filipek, P.A., Bakardjiev, A.I., Hodgson, J., Takeoka, M., Makris, N., et al. Brain asymmetries in autism and developmental language disorder: A nested whole-brain analysis. Brain 2005, 128, 213-226. [CrossRef] [PubMed]
188. Herbert, M.R., Ziegler, D.A., Deutsch, C.K., O’Brien, L.M., Lange, N., Bakardjiev, A., Hodgson, J., Adrien, K.T., Steele, S., Makris, N., et al. Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. Brain 2003, 126, 1182-1192. [CrossRef] [PubMed]
189. Won, H., Mah, W., Kim, E. Autism spectrum disorder causes, mechanisms, and treatments: Focus on neuronal synapses. Front. Mol. Neurosci. 2013, 6, 19. [CrossRef] [PubMed]
190. Poduslo, S.E., Jang, Y. Myelin development in infant brain. Neurochem. Res. 1984, 9, 1615-1626. [CrossRef] [PubMed]
191. Yehuda, S., Rabinovitz, S., Mostofsky, D.I. Essential fatty acids and the brain: From infancy to aging. Neurobiol. Aging 2005, 26, 98-102. [CrossRef] [PubMed]
192. Richardson, A.J., Ross, M.A. Fatty acid metabolism in neurodevelopmental disorder: A new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot. Essent. Fatty Acids 2000, 63, 1-9. [CrossRef] [PubMed]
193. Burdge, G.C., Wootton, S.A. Conversion of α-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br. J. Nutr. 2002, 88, 411-420. [CrossRef] [PubMed]
194. Van Elst, K., Bruining, H., Birtoli, B., Terreaux, C., Buitelaar, J.K., Kas, M.J. Food for thought: Dietary changes in essential fatty acid ratios and the increase in autism spectrum disorders. Neurosci. Biobehav. Rev. 2014, 45, 369-378. [CrossRef] [PubMed]
195. Hamazaki, T., Hamazaki, K. Fish oils and aggression or hostility. Prog. Lipid Res. 2008, 47, 221-232. [CrossRef] [PubMed]
196. Hashemi, E., Ariza, J., Rogers, H., Noctor, S.C., Martinez-Cerdeno, V. The number of parvalbumin-expressing interneurons is decreased in the medial prefrontal cortex in autism. Cereb. Cortex 2016. [CrossRef] [PubMed]
197. Filice, F., Vorckel, K.J., Sungur, A.O., Wohr, M., Schwaller, B. Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism. Mol. Brain 2016, 9, 10. [CrossRef] [PubMed]
198. D’Hulst, C., Atack, J.R., Kooy, R.F. The complexity of the gabaa receptor shapes unique pharmacological profiles. Drug Discov. Today 2009, 14, 866-875. [CrossRef] [PubMed]
199. Schwartz, R.D., Yu, X. Inhibition of gaba-gated chloride channel function by arachidonic acid. Brain Res. 1992, 585, 405-410. [CrossRef]
200. Takeuchi, T., Iwanaga, M., Harada, E. Possible regulatory mechanism of DHA-induced anti-stress reaction in rats. Brain Res. 2003, 964, 136-143. [CrossRef]
201. Das, U.N. Autism as a disorder of deficiency of brain-derived neurotrophic factor and altered metabolism of polyunsaturated fatty acids. Nutrition 2013, 29, 1175-1185. [CrossRef] [PubMed]
202. Stevens, L.J., Zentall, S.S., Deck, J.L., Abate, M.L., Watkins, B.A., Lipp, S.R., Burgess, J.R. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am. J. Clin. Nutr. 1995, 62, 761-768. [PubMed]
203. Antalis, C.J., Stevens, L.J., Campbell, M., Pazdro, R., Ericson, K., Burgess, J.R. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75, 299-308. [CrossRef] [PubMed]
204. Konikowska, K., Regulska-Ilow, B., Rozanska, D. The influence of components of diet on the symptoms of ADHD in children. Rocz. Panstwowego Zakl. Hig. 2012, 63, 127-134.
205. Ottoboni, F., Ottoboni, A. Can attention deficit-hyperactivity disorder result from nutritional deficiency? J. Am. Phys. Surg. 2003, 8, 58-60.
206. Voigt, R.G., Llorente, A.M., Jensen, C.L., Fraley, J.K., Berretta, M.C., Heird, W.C. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J. Pediatr. 2001, 139, 189-196. [CrossRef] [PubMed]
207. Richardson, A.J., Puri, B.K. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on adhd-related symptoms in children with specific learning difficulties. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2002, 26, 233-239. [CrossRef]
208. Gillies, D., Sinn, J., Lad, S.S., Leach, M.J., Ross, M.J. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database Syst. Rev. 2012, 7, CD007986. [CrossRef] [PubMed]
209. Colter, A.L., Cutler, C., Meckling, K.A. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: A case-control study. Nutr. J. 2008, 7, 8. [CrossRef] [PubMed]
210. Chen, J.R., Hsu, S.F., Hsu, C.D., Hwang, L.H., Yang, S.C. Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan. J. Nutr. Biochem. 2004, 15, 467-472. [CrossRef] [PubMed]
211. Ng, K.H., Meyer, B.J., Reece, L., Sinn, N. Dietary PUFAintakes in children with attention-deficit/hyperactivity disorder symptoms. Br. J. Nutr. 2009, 102, 1635-1641. [CrossRef] [PubMed]
212. Ross, W.J., Chan, E., Harris, S.K., Goldman, S.J., Rappaport, L.A. Pediatrician-psychiatrist collaboration to care for children with attention deficit hyperactivity disorder, depression, and anxiety. Clin. Pediatr. 2011, 50, 37-43. [CrossRef] [PubMed]
213. Kuperstein, F., Yakubov, E., Dinerman, P., Gil, S., Eylam, R., Salem, N., Yavin, E. Overexpression of dopamine receptor genes and their products in the postnatal rat brain following maternal n-3 fatty acid dietary deficiency. J. Neurochem. 2005, 95, 1550-1562. [CrossRef] [PubMed]
214. Liu, J.J., Green, P., John Mann, J., Rapoport, S.I., Sublette, M.E. Pathways of polyunsaturated fatty acid utilization: Implications for brain function in neuropsychiatric health and disease. Brain Res. 2015, 1597, 220-246. [CrossRef] [PubMed]
215. De la Presa Owens, S., Innis, S.M. Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and α-linolenic acid deficient diet in formula-fed piglets. J. Nutr. 1999, 129, 2088-2093. [PubMed]
216. Zimmer, L., Hembert, S., Durand, G., Breton, P., Guilloteau, D., Besnard, J.C., Chalon, S. Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: A microdialysis study. Neurosci. Lett. 1998, 240, 177-181. [CrossRef]
217. Kuperstein, F., Eilam, R., Yavin, E. Altered expression of key dopaminergic regulatory proteins in the postnatal brain following perinatal n-3 fatty acid dietary deficiency. J. Neurochem. 2008, 106, 662-671. [CrossRef] [PubMed]
218. Liu, J.J., Galfalvy, H.C., Cooper, T.B., Oquendo, M.A., Grunebaum, M.F., Mann, J.J., Sublette, M.E. Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders. J. Clin. Psychiatry 2013, 74, 732-738. [CrossRef] [PubMed]
219. Jacka, F.N., Maes, M., Pasco, J.A., Williams, L.J., Berk, M. Nutrient intakes and the common mental disorders in women. J. Affect. Disord. 2012, 141, 79-85. [CrossRef] [PubMed]
220. World Health Organization (WHO). Fats and fatty acids in human nutrition. FAO Food Nutr. Pap. 2010, 91, 1-166.
221. Legrand, P. New French Nutritional Recommendations for Fatty Acids; FAO: Rome, Italy, 2013.